VC  Montreux Equity Partners

http://www.mepvc.com/





     Office Locations:

One Ferry Building, Suite 255
San Francisco, CA 94111
Phone: 650-234-1200
Fax: 650-234-1250

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1993, Montreux Equity Partners is a venture capital firm focused on pharmaceutical and medical device companies. Montreux is currently investing out of its fourth fund, MEP IV, a $250 million fund. Montreux's investment ranges from $2-$5 million in any given financing, and up to $12 million over the life cycle of the investment. Montreux typically invests in the first institutional capital raising of clinical and commercialization stage companies.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Daniel K. Turner Managing Director
    Howard D. Palefsky Managing Director
    Jessica Hou Principal
    John J. Savarese MD Managing Director
    Matt Lambert Principal

     

    Portfolio companies include:


      ARYx
        web link


      Asthmatx
        web link


      Avantis
        web link


      Avera
        web link


      Bayhill Therapeutics
        web link


      Cerexa
        web link


      Coalescent Surgical
        web link


      Colorescience
        web link


      Enteric Medical Technologies
        web link


      GC Aesthetics
        web link


      Glaukos
        web link


      Integrated Biosystems
        web link


      KFx Medical
        web link


      MAKO Surgical Corp
        web link


      Mindbody
        web link


      Moksha8
        web link


      NeurogesX
        web link


      NovaCardia
        web link


      Novalar Pharmaceuticals
        web link


      NovoStent
        web link


      OREXIGEN Therapeutics
        web link


      Peninsula Pharmaceuticals
        web link


      Percutaneous Systems
        web link


      Pivot Medical
        web link


      Pro-Duct Health
        web link


      PulmonX
        web link


      Pure Life Renal
        web link


      Questcor Pharmaceuticals
        web link


      Renal CarePartners
        web link


      Sequel Pharmaceuticals
        web link


      SI-Bone
        web link


      SkinMedica
        web link


      Somaxon
        web link


      Tobira Therapeutics
        web link


      Transcept
        web link


      Verus
        web link


     

    Recent News: